Kujacic V, Eliasson T, Mannheimer C, Jablonskiene D, Augustinsson L E, Emanuelsson H
Division of Cardiology, Sahlgrenska Hospital, Göteburg, Sweden.
Eur Heart J. 1993 Sep;14(9):1238-44. doi: 10.1093/eurheartj/14.9.1238.
Patients with severe, widespread coronary atherosclerosis and patients who have undergone several coronary artery bypass operations are often poor candidates for coronary bypass surgery (CABG). Spinal cord stimulation (SCS) has been shown to have an anti-anginal effect that is probably associated with an anti-ischaemic effect. In the present investigation, 15 patients with severe angina (mean age 64 years, range 49-71) were studied. All patients had a history of intractable angina pectoris despite optimal medical treatment and previous coronary bypass operation. The patients had multi-vessel disease and graft occlusion or graft stenosis on postoperative coronary angiograms. Left ventricular function was assessed echocardiographically at rest and during provocation with adenosine infusion in a control session without treatment and during treatment with SCS. The recovery time was at least 3 h. The decrease in the ejection fraction during adenosine infusion was more pronounced in the control situation (44 to 37%; P < 0.05) than during SCS (48 to 44%; ns), and the time to echocardiographic signs of dysfunction and to anginal pain during adenosine infusion was significantly prolonged during SCS (P < 0.001). In addition, the recovery time for these parameters was shorter during SCS (P < 0.001). It is concluded that the deterioration in left ventricular function during adenosine provocation was less pronounced with SCS than without. This possible anti-ischaemic effect is in agreement with results from earlier studies.
患有严重、广泛冠状动脉粥样硬化的患者以及接受过多次冠状动脉搭桥手术的患者通常不太适合进行冠状动脉搭桥手术(CABG)。脊髓刺激(SCS)已被证明具有抗心绞痛作用,这可能与抗缺血作用有关。在本研究中,对15例严重心绞痛患者(平均年龄64岁,范围49 - 71岁)进行了研究。所有患者尽管接受了最佳药物治疗且之前进行过冠状动脉搭桥手术,但仍有顽固性心绞痛病史。患者有多支血管病变,术后冠状动脉造影显示有移植血管闭塞或移植血管狭窄。在未治疗的对照阶段以及SCS治疗期间,通过超声心动图评估静息和腺苷输注激发时的左心室功能。恢复时间至少为3小时。腺苷输注期间射血分数的下降在对照情况下(从44%降至37%;P < 0.05)比SCS治疗期间(从48%降至44%;无显著性差异)更明显,并且腺苷输注期间出现功能障碍超声心动图征象和心绞痛的时间在SCS治疗期间显著延长(P < 0.001)。此外,SCS治疗期间这些参数的恢复时间更短(P < 0.001)。结论是,与未使用SCS相比,腺苷激发期间SCS治疗时左心室功能的恶化不那么明显。这种可能的抗缺血作用与早期研究结果一致。